Verseau Therapeutics competitorsClear all
Verseau Therapeutics's top competitors include Boundless Bio, FoRx Therapeutics, Intrepida Bio and Curis.
| Save Comparison |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. |  Boundless Bio Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. |  FoRx Therapeutics FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. |  Intrepida Bio Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. |  Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |
Founding Date | Founding Date 2017 | Founding Date 2019 | Founding Date 2019 | Founding Date 2019 | Founding Date 2000 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Bedford, US HQ | Locations San Diego, US HQ | Locations Basel, CH HQ | Locations San Diego, US HQ | Locations Lexington, US HQ Lexington, US |
Employees | Employees 225% increase | Employees 343% increase | Employees 717% increase | Employees N/A | Employees 3144% decrease |
Twitter followers | Twitter followers 45 | Twitter followers 145 | Twitter followers 44 | Twitter followers N/A | Twitter followers 173 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 220477 | Alexa Website Rank N/A | Alexa Website Rank 537337 | Alexa Website Rank 247371 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.6 |
Funding | |||||
Latest funding round | Latest funding round $ 50m (over 1 year ago) | Latest funding round $ 46.4m (over 1 year ago) | Latest funding round $ 10.8m (9 months ago) | Latest funding round $ 9.5m (over 1 year ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 46.4m | Total funding raised $ 10.8m | Total funding raised $ 9.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Boundless Bio
HQ
San Diego, US
Employees
34↑ 3% increase
Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers.
View companyFoRx Therapeutics
HQ
Basel, CH
Employees
7↑ 17% increase
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
View companyIntrepida Bio
HQ
San Diego, US
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.
View companyCuris
HQ
Lexington, US
Employees
31↓ 44% decrease
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View company